Spinal cord injury

Terebellum and NeurosolvTherapeutics will partner to launch Perineline, a new patented two-part therapy for spinal cord injuries.  The drug has attained EMA Orphan Designation and it is hoped that it will revolutionise the therapeutic treatment and resulting end patient outcomes from spinal cord injuries.   Terebellum will contribute strategic guidance in the pre-commercialisation stage, market access […]

A group of latent stem cells could be the key to developing new therapeutic approaches to treat brain and spinal cord injuries, research shows. Scientists at the Francis Crick Institute identified a group of latent stem cells in mice which respond to injury in the central nervous system. If the same group is found in […]

An existing drug could help reduce spinal cord injury damage, scientists at the University of Birmingham have discovered.   A team of scientists from the University of Birmingham found that an enzyme inhibitor developed by AstraZeneca can significantly reduce ‘secondary damage’ caused by the body’s response to spinal cord injury.   The team used animal models to […]